Abdominal and Digestive System Associations of Familial Mediterranean Fever

American Journal of Gastroenterology

Volumn 98, Issue 12, 2003, Pages 2594-2604

  Mor, Adam ^b   Gal, Rivka ^b   Livneh, Avi ^a  

^a HELLER INSTITUTE OF MEDICAL RESEARCH   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; COLCHICINE; CYCLOSPORIN A;

ABDOMEN; ABDOMINAL PAIN; AMYLOID NEUROPATHY; AMYLOIDOSIS; ARTHRALGIA; ASCITES; CONSTIPATION; DIAGNOSTIC IMAGING; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM; DISEASE ASSOCIATION; DRUG ABSORPTION; DRUG METABOLISM; DRUG POTENTIATION; ENTERITIS; FAMILIAL MEDITERRANEAN FEVER; FEVER; FMF GENE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; GENE; GENE MUTATION; GENETIC DISORDER; HEARTBURN; HUMAN; ILEUS; INTESTINE INFARCTION; INTESTINE ULCER; IRRITABLE COLON; LIVER METABOLISM; MALABSORPTION; MOLECULAR CLONING; MUSCLE CRAMP; MYALGIA; NEUROPATHY; PARALYTIC ILEUS; PATHOGENESIS; PERITONITIS; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS; THORAX PAIN; VASCULITIS; VOMITING;

EID: 0347994983     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.08784.x     Document Type: Review

References (94)

1. Drenth JPH, van der Meer JWM. Hereditary periodic fever. N Engl J Med 2001;345:1748-57.
2. Touitou I. The spectrum of familial Mediterranean fever mutations. Eur J Hum Genet 2001;9:473-83.
3. Mor A, Zaks N, Shinar Y, et al. A novel severity scoring system for FMF. Clin Exp Rheumatol 2002;20(suppl 26):S-88. (Abstract).
4. Shinar Y, Livneh A, Langevitz P, et al. Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol 2000;27:1703-7.
5. Gershoni-Baruch R, Brik R, Shinawi M, et al. The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet 2002;10:145-9.
6. International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997;90:797-807.
7. Gumucio DL, Diaz A, Schaner P, et al. Fire and ICE. The role of pyrin domain-containing proteins in inflammation and apoptosis. Clin Exp Rheumatol 2002;20(Suppl. 26):S45-53.
8. Livneh A, Langevitz P, Zemer D, et al. Criteria for diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879-85.
9. Livneh A, Langevitz P. Diagnostic and treatment concerns in familial Mediterranean fever. Bailliere's Clin Rheumatol 2000;14:477-98.
10. Langevitz P, Livneh A, Padeh S, et al. Familial Mediterranean fever. New aspects and prospects at the end of the millennium. Isr Med Assoc J 1999;1:31-6.
11. Korkmaz C, Ozdogan H, Kasapcopur O, et al. Acute phase response in familial Mediterranean fever. Ann Rheum Dis 2002;61:79-81.
12. Resissman P, Durst AL, Rivkind A, et al. Elective laparoscopic appendectomy in patients with familial Mediterranean fever. Word J Surg 1994;18:139-41.
13. Ehrenfeld EN, Polishuk WZ. Gynecological aspects of recurrent polyserositis. Isr J Med Sci 1970;6:9-14.
14. Golden RL, Weigers EW, Meagher JG. Periodic fever and menses. Am J Obstet Gynecol 1973;117:855-6.
15. Bodel P, Dillard GM. Supression of periodic fever with estrogen. Arch Intern Med 1973;131:189-95.
16. Kats BA. Letter. Estrogen therapy for periodic fever. Arch Intern Med 1974;133:868-9.
17. Ciftci AO, Cahit Tanyel F, Buyukpamukcu N, et al. Adhesive small bowel obstruction caused by familial Mediterranean fever: The incidence and outcome. J Ped Surg 1995;30:577-9.
18. Michaeli D, Pras M. Intestinal strangulation complicating familial Mediterranean fever. Br Med J 1966;2:30-1.
19. Livneh A, Langevitz P, Zemer D, et al. The changing face of familial Mediterranean fever. Semin Arthritis Rheum 1996;26:612-27.
20. Bellin MF, Deutsch JP, Bletry O, et al. Encapsulating peritonitis in periodic disease. Ann Radiol 1989;32:302-4.
21. Bitar E, Rizk A, Nasr W, et al. Familial paroxysmal polyserositis. Previously unpublished peritoneal complications. Presse Med 1985;14:586-8.
22. Lelievre JD, Ranque-Francois B, Aslangul-Castier E, et al. Chronic ascites related to encapsulating peritonitis in familial Mediterranean fever. Am J Med 2002;113:80-1.
23. Zaks N, Tokov I, Shinar Y, et al. Parameters associated with prolonged delay (>10 years) in the diagnosis of FMF. Clin Exp Rheumatol 2002;20(Suppl. 26):S93-4 (Abstract).
24. Friedman S, Janowitz HD. Systemic amyloidosis and the gastrointestinal tract. Gastroenterol Clin North Am 1998;27:595-614.
25. Knecht M, de Beer FC, Pras M. Serum amyloid A protein in familial Mediterranean fever. Ann Intern Med 1985;102:71-2.
26. Sohar E, Gafni J, Pras M, et al. Familial Mediterranean fever: A survey of 470 cases and review of the literature. Am J Med 1967;43:227-53.
27. Heller H, Sohar E, Gafni J, et al. Amyloidosis in familial Mediterranean fever. An independent genetically determined character. Arch Intern Med 1961;107:539-56.
28. Pras M, Bronshpigel N, Zemer D, et al. Variable incidence of amyloidosis in familial Mediterranean fever among different groups. Johns Hopkins Med J 1982;150:22-6.
29. Gafni J, Ravid M, Sohar E. The role of amyloidosis in familial Mediterranean fever. A population study. Isr J Med Sci 1968;4:995-9.
30. Cazeneuve C, Ajrapetyan H, Papin S, et al. Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 2000;67:1136-43.
31. Kavukce S, Turkmen M, Eroglu Y, et al. Renal, gastric and thyroidal amyloidosis due to familial Mediterranean fever. Pediatr Nephrol 1997;11:210-2.
32. Clotet B, Navas J, Grifol M, et al. Liver sinusoidal dilatation in FMF. Arch Intern Med 1986;146:1243-4.
33. Arutiunian VM, Eganian GA, Khachatrian VA, et al. Selective involvement of the gastrointestinal tract in amyloidosis in a female patient with periodic disease and intact kidneys. Ter Arkh 1991;63:117-20.
34. Saatci U, Bakkaloglu A, Ozen S, et al. Familial Mediterranean fever and amyloidosis in children. Acta Paediatr 1993;81:705-6.
35. Ravid M, Sohar E. Intestinal malabsorption: First manifestation of amyloidosis in familial Mediterranean fever. Report of two cases. Gastroenterology 1974;66:446-9.
36. Yeganian GA. Isolated amyloidosis of the gastrointestinal tract in familial Mediterranean fever. Clin Exp Rheumatol 2002;20(Suppl 26):S-98 (Abstract).
37. Kyzer S, Zevin D, Chagnac A, et al. Ischemic colitis complicating AA amyloidosis and familial Mediterranean fever. Isr J Med Sci 1993;29:212-4.
38. Nazaretyan EY, Gasparyan AY. Portal hypertension in familial Mediterranean fever. Clin Exp Rheumatol 2002;20:S-98.
39. Clotet B, Navas J, Grifol M, et al. Liver sinusoidal dilatation in familial Mediterranean fever. Arch Intern Med 1986;146:1243-3.
40. Tishler M, Pras M, Yaron M. Abdominal fat tissue aspirate in amyloidosis of familial Mediterranean fever. Clin Exp Rheumatol 1988;6:395-7.
41. Gafni J, Sohar E. Rectal biopsy for the diagnosis of amyloidosis. Am J Med Sci 1960;240:332-6.
42. Cattan D, Notarnicola C, Molinari N, et al. Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever. Lancet 2000;355:378-9.
43. Fidder HH, Chowers Y, Lidar M, et al. Crohn disease in patients with familial Mediterranean fever. Medicine 2002;81:411-6.
44. Cavanaugh JA, Callen DF, Wilson SR, et al. Analysis of Australian Crohn's disease pedigree refines the localization for susceptibility to inflammatory bowel disease on chromosome 16. Ann Hum Genet 1998;62:291-8.
45. Inohara N, Nunez G. The NOD: A signaling module that regulates apoptosis and host defence against pathogenes. Oncogene 2001;20:6473-81.
46. Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002;122:867-74.
47. Khan MA. Update on spondyloarthropathies. Ann Intern Med 2002;136:896-907.
48. Crane AM, Bradbury L, van Heel DA, et al. Role of NOD2 variants in spondyloarthritis. Arthritis Rheum 2002;46:1629-33.
49. Pras M, Langevitz P, Livneh A, et al. Vasculitis in familial Mediterranean fever. In: Ansell NM, Bacon PA, Lie JT, eds. The vasculitides: Science and practice. Chapman & Hall Medical, 1996:412-6.
50. Ozdogan H, Arisoy N, Kasapkapur O, et al. Vasculitis in familial Mediterranean fever. J Rheumatol 1997;24:323-7.
51. Flatau E, Kohn D, Schiller D, et al. Schönlein-Henoch syndrome in patients with familial Mediterranean fever. Arthritis Rheum 1982;25:42-7.
52. th ed. Arthritis Foundation, Atlanta, Georgia, USA 2001:385-91.
53. Sachs D, Langevitz P, Morag B, et al. Polyarteritis nodosa and familial Mediterranean fever. Br J Rheumatol 1987;26:139-41.
54. Henckes M, Roskams T, Vanneste S, et al. Polyarteritis nodosa type vasculitis in a patient with familial Mediterranean fever treated with cyclosporine A. Transplant Int 1994;7:292-6.
55. th ed. New York: McGraw-Hill, 2001:1956-68.
56. Glikson M, Galun E, Schlezinger M, et al. Polyarteritis nodosa and familial Mediterranean fever. A report of two cases and review of the literature. J Rheum 1989;16:536-9.
57. Langevitz P, Zemer D, Livneh A, et al. Protracted febrile myalgia in patients with familial Mediterranean fever. J Rheumatol 1994;21:1708-9.
58. Sidi G, Shinar Y, Livneh A, et al. Protracted febrile myalgia of familial Mediterranean fever. Scand J Rheumatol 2000;29:174-6.
59. Schwartz T, Langevitz P, Zemer D, et al. Bechçet's disease in familial Mediterranean fever. Characterization of the association between the two diseases. Semin Arthritis Rheum 2000;29:286-95.
60. Katz J, Langevitz P, Shemer J, et al. Prevention of recurrent aphthous stomatitis with colchicine: An open trial. J Am Acad Dermatol 1994;31:459-61.
61. Yunus M, Masi AT, Calabro JJ, et al. Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981;11:151-71.
62. Brik R, Litmanovitz D, Berkowitz D, et al. Incidence of familial Mediterranean fever (FMF) mutations among children of Mediterranean extraction with functional abdominal pain. J Pediatr 2001;138:759-62.
63. Rimon D, Meir Y, Cohen L. Retroperitoneal lymphadenopathy in familial Mediterranean fever. Postgrad Med J 1989;65:776-8.
64. Kushnir T, Livneh A, Langevitz P, et al. Magnetic resonance imaging of familial Mediterranean fever. Proceedings of the 12th meeting of the Society of Magnetic Resonance in Medicine, 1993;2:822-3.
65. Heller H, Sohar E, Sherf L. Familial Mediterranean fever. Arch Intern Med 1958;102:50-71.
66. Guven AG, Bahat E, Akam S, et al. Late diagnosis of severe colchicine intoxication. Pediatrics 2002;109:971-3.
67. 12 malabsorption in patients receiving colchicine. N Engl J Med 1968;279:845-50.
68. Neequaye J, Jelly AE. Acute hepatitis in recurrent hereditary polyserositis (familial Mediterranean fever). J Trop Pediatr 1994;40:243-5.
69. Guardia J, Vilaseca J, Moragas A, et al. Hepatitis in exanthemaus Mediterranean fever. Hepatogastroenterology 1981;28:81-3.
70. Moretti G, Le Bras M, Longy M, et al. Familial Mediterranean fever and fatty liver. Effect of a long time colchicine treatment on triglyceride storage. Ann Intern Med 1981;132:482-6.
71. th ed. Philadelphia: WB Saunders, 1992:1140-1.
72. Chahinian AP, Pajak TF, Holland JF, et al. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Intern Med 1982;96:746-55.
73. Gentiloni N, Febbraro S, Barone C, et al. Peritoneal mesothelioma in recurrent familial peritonitis. J Clin Gastroenterol 1997;24:276-9.
74. Belange G, Gompel H, Chaouat Y, et al. Malignant peritoneal mesothelioma occurring in periodic disease: Apropos of a case. Rev Med Inerne 1998;19:427-30.
75. Livneh A, Langevitz P, Pras M, et al. Pulmonary associations in familial Mediterranean fever. Curr Opin Pul Med 1999;5:326-31.
76. Ozaltin F, Bakkaloglu A, Saltik IN, et al. Helicobacter pylori infection in Turkish children with familial Mediterranean fever: Is it a causative agent inducing inflammation? Clin Exp Rheumatol 2002;20(suppl 26):S-87 (Abstract).
77. Ben-Chetrit E, Levy M. Colchicine: Update. Semin Arthritis Rheum 1998;28:48-59.
78. Zemer D, Pras M, Sohar E, et al. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986;314:1001-5.
79. Halkin H, Dany S, Greenwald M, et al. Colchicine kinetics in patients with familial Mediterranean fever. Clin Pharmacol 1980;28:82-7.
80. Yussim A, Bar-Nathan N, Lustig S, et al. Gastointestinal, hepatorenal and neuromuscular toxicity caused by cyclosporine-colchicine interaction in renal transplantation. Transplant Proc 1994;26:2825-6.
81. Lidar M, Kedem R, Langevitz P, et al. Intravenous colchicines treatment for FMF patients unresponsive to oral colchicines therapy. Clin Exp Rheumatol 2002;20(suppl 26):S-105 (Abstract).
82. Dinarello CA, Chusid MJ, Fauci AS, et al. Effect of prophylactic colchicines therapy on leukocyte function in patients with familial Mediterranean fever. Arthritis Rheum 1976;19:618-22.
83. Molad Y, Reibman J, Levin RI, et al. A new mode of action for an old drug: Colchicine decrease surface expression of adhesion molecule on both neutrophils (Pms) and endothelium. Arthritis Rheum 1992;35(suppl):S35 (Abstract).
84. Allen JN, Herzyk OJ, Wewers MD. Colchicine has an opposite effect on interleukin 1b and tumor necrosis factor. Am J Physiol 1991;261:315-21.
85. Ehrenfeld M, Levy M, Sharon P, et al. Gastrointestinal effects of long-term colchicines therapy in patients with recurrent polyserositis (familial Mediterranean fever). Dig Dis Sci 1982;27:723-7.
86. Fradkin A, Yahav J, Zemer D, et al. Colchicine-induced lactose malabsorption in patients with familial Mediterranean fever. Isr J Med Sci 1995;31:616-20.
87. Hawkins PN. Evaluation, significance and treatment of inflammation in the inherited periodic fever syndromes. Clin Exp Rheumatol 2002;20:S-66-7.
88. Tunca M, Tankurt E, Akbaylar Akpinar H, et al. The efficacy of interferon alpha on colchicine-resistant familial Mediterranean fever attacks: A pilot study. Br J Rheumatol 1997;36:1005-8.
89. Seyahi E, Ozdogan S, Masatlioglu S, et al. Successful treatment of familial Mediterranean fever attacks with thalidomide in a colchicine resistant patient. Clin Exp Rheumatol 2002;20 (Suppl 26):S43-4 (Abstract).
90. Aharoni D, Hiller N, Hadas-Halpern I. Familial Mediterranean fever: Abdominal imaging findings in 139 patients and review of the literature. Abdom Imaging 2000;25:297-300.
91. Apter S, Zemer D, Terhakopian A, et al. Abdominal CT findings in nephropathic amyloidosis of familial Mediterranean fever. Amyloid 2001;8:58-64.
92. Gillmore JD, Lovat LB, Presey MR, et al. Amyloid load and outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001;358:24-9.
93. Gonzalez JA, Molinero M, Sayans D, et al. Colonic perforation by amyloidosis: Report of a case. Dis Colon Rectum 1989;32:437.
94. Kumar SS, Appavu SS, Abcarian H, et al. Amyloidosis of the colon: Report of a case and review of the literature. Dis Colon Rectum 1983;26:541.